Oligometastatic Prostate Cancer (DBCOND0061767)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT02192788	Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer	No drug interventions	treatment	Not Available	completed
NCT06387056	Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)	Cisplatin Docetaxel Goserelin Pamiparib Rezvilutamide Tislelizumab	treatment	2	recruiting
NCT06060652	Prostate Oligometastatic Cancer Management Driven by Disease Biology et/or Immunoactivity (PROMETEO)	No drug interventions	Not Available	Not Available	recruiting
NCT05560659	Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy	Lutetium Lu-177	treatment	2	recruiting
NCT04992026	The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer	Abiraterone Luteinizing hormone Prednisone acetate	treatment	2	active_not_recruiting
NCT01859221	Radiotherapy for Oligometastatic Prostate Cancer	No drug interventions	treatment	Not Available	completed
NCT05915442	Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer	Etrumadenant Quemliclustat Zimberelimab	treatment	2	recruiting
NCT03940235	Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis	No drug interventions	treatment	2	recruiting
NCT04610372	5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)	No drug interventions	treatment	Not Available	recruiting